Skip to main content

Table 1 Patients’ characteristics

From: Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients

  Total Group D Group A Group P P value
N 44 12 14 18  
Sex (m/f) 30/14 9/3 9/5 12/6 0.829
Age (mean ± SD) 70.8 ± 11.8 69.6 ± 14.3 74.1 ± 12.1 69.1 ± 9.8 0.335
 (median) 72.0 69.5 80.0 70.5  
Hypertension 68.2% 66.7% 50% 83.3% 0.132
Dyslipidemia 29.5% 8.3% 28.6% 44.4% 0.104
Diabetes 38.6% 33.3% 21.4% 55.6% 0.131
Atrial fibrillation 34.1% 58.3% 57.1% 0% < 0.001
Smoking 54.5% 66.7% 57.1% 44.4% 0.475
Stroke subtype (n)      < 0.001
 CE 23 9 14 0  
 LAA 10 2 0 8  
 SVO 11 1 0 10  
  1. CE cardioembolism, LAA large artery atherothrombosis, SAO small vessel occlusion